From local player to global market leader and consolidator in the market of pharmaceutical compounding

Fagron Hellas

Fagron Hellas is headquartered in Trikala, Greece. The company has continued to grow through the years because of its innovation and ability to bring new products/services to the Greek market and its activity focused on the development of compounding, to strengthen the scientific role of pharmacists.

The quality and excellence of the pharmaceutical raw materials, services and solutions represent the means to ensure the total satisfaction of compounding pharmacists. Fagron Hellas specializes in the supply of active pharmaceutical ingredients (APIs and excipients), innovative vehicles and compounding solutions, pharmaceutical packaging, pharmacy laboratory equipment, glassware and accessories, pharmacy equipment.

The company, as part of the group Fagron, represented worldwide in 32 countries, in Europe, America, Africa, Asia, Oceania has the opportunity to access a database of ideas and innovative raw materials, which, together with points strength as quality, flexibility, innovation and product development are key factors of the portfolio by introducing new products on Balkan compounding market.

Fagron Hellas has the chance to use of the global network and the operational structure of highly qualified Fagron through purchasing centers located in America, Europe and Asia and rewrapping centers Fagron in different countries can rely on the supply of raw materials constant, selected and approved according to most stringent industry standards. It is particularly important that the Fagron Hellas production site works as export activity station for Fagron group in several countries of Europe, because of the highest level of quality assurance and applied security technology for the products produced.


About Fagron

Fagron was founded in Rotterdam (the Netherlands) by Ger van Jeveren in 1990. Through a continuous focus on innovation, quality and solution-oriented thinking, Fagron obtained market leadership in specialty pharma in the Netherlands in just 7 years. Fagron’s successful strategy of optimizing and innovating customized pharmaceutical care in order to widen the therapeutic options of prescribers worldwide and improving patients’ quality of life, its unique business model and the investments in innovation and product development resulted in the fact that Fagron is currently leading in specialty pharma and is active in 32 countries in Europe, the Americas, the Middle East, Africa, Asia and the Pacific. Fagron products and innovations are sold to over 200,000 customers in over 60 countries around the world.

Fagron is active in the following segments of Specialty Pharma:

  • Fagron Specialty Pharma Services: Customized medication that is prepared in Fagron’s 22 sterile, nuclear and non-sterile compounding facilities in Europe, North America, South America and South Africa.
  • Fagron Trademarks: Innovative concepts, vehicles and formulations for specialty pharma that are developed by Fagron's R&D team, often in close cooperation with prescribers, pharmacies and universities.
  • Fagron Essentials: Pharmaceutical raw materials, equipment and supplies that pharmacists need in order to be able to prepare medication in the pharmacy.


Fagron mission and strategy

Fagron’s strategy is focused on optimizing and innovating customized pharmaceutical care in order to widen the therapeutic options of prescribers worldwide. As a R&D scientific specialty pharma company, we are supporting the unique selling point of customized medication and improving patients’ quality of life.  


Fagron Unique Quality